Different MRI-based radiomics machine learning models to predict CD3+ tumor-infiltrating lymphocytes in rectal cancer.

Front Oncol

Department of Radiology, Shaoxing People's Hospital, Key Laboratory of Functional Molecular Imaging of Tumor and Interventional Diagnosis and Treatment of Shaoxing City, Shaoxing, China.

Published: April 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: This study aimed to develop and evaluate multiple machine learning models utilizing contrast-enhanced T1-weighted imaging (T1-CE) to differentiate between low-/high-infiltration of total T lymphocytes (CD3) in patients with rectal cancer.

Methods: We retrospectively selected 157 patients (103 men, 54 women) with pathologically confirmed rectal cancer diagnosed between March 2015 and October 2019. The cohort was randomly divided into a training dataset (n=109) and a test dataset (n=48) for subsequent analysis. Seven radiomic features were selected to generate three models: logistic regression (LR), random forest (RF), and support vector machine (SVM). The diagnostic performance of the three models was compared using the DeLong test. Additionally, Kaplan-Meier analysis was employed to assess disease-free survival (DFS) in patients with high and low CD3+ tumor-infiltrating lymphocyte (TIL) density.

Results: The three radiomics models performed well in predicting the infiltration of CD3+ TILS, with area under the curve (AUC) values of 0.871, 0.982, and 0.913, respectively, in the training set for the LR, RF, and SVM models. In the validation set, the corresponding AUC values were 0.869, 0.794, and 0.837, respectively. Among the radiomics models, the LR model exhibited superior diagnostic performance and robustness. The merged model, which integrated radiomics features from the SVM model and clinical features from the clinical model, outperformed the individual radiomics models, with AUCs of 0.8932 and 0.8829 in the training and test cohorts, respectively. Additionally, a lower expression level of CD3+ TILs in the cohort was independently correlated with DFS ( = 0.0041).

Conclusion: The combined model demonstrated a better discriminatory ability in assessing the abundance of CD3+ TILs in rectal cancer. Furthermore, the expression of CD3+ TILs was significantly correlated with DFS, highlighting its potential prognostic value.

Advances In Knowledge: This study is the first attempt to compare the predictive TILs performance of three machine learning models, LR, RF, and SVM, based on the combination of radiomics and immunohistochemistry. The MRI-based combined model, composed of radiomics features from the SVM model and clinical features from the clinical model, exhibited better discriminatory capability for the expression of CD3+ TILs in rectal cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12066337PMC
http://dx.doi.org/10.3389/fonc.2025.1509207DOI Listing

Publication Analysis

Top Keywords

cd3+ tils
20
rectal cancer
16
machine learning
12
learning models
12
radiomics models
12
models
9
cd3+ tumor-infiltrating
8
three models
8
diagnostic performance
8
performance three
8

Similar Publications

γδ T cells are the prime antitumoral T cells in pediatric neuroblastoma.

Life Sci Alliance

November 2025

Sanquin Blood Supply Foundation, Department of Research, T Cell Differentiation Lab, Amsterdam, The Netherlands

High-risk pediatric neuroblastoma patients have a dismal survival rate despite intensive treatment regimens. New treatment options are thus required. Even though HLA expression in neuroblastoma is low and immune cell infiltrates are limited, the presence of tumor-infiltrating lymphocytes (TILs) is indicative of better patient survival.

View Article and Find Full Text PDF

Fast tumor-infiltrating lymphocytes (TILs): rapid manufacture of an adoptive cellular therapeutic from pleural infiltrating T cells for intrapleural administration.

Cytotherapy

August 2025

Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania, USA; Allegheny Health Network Research Institute, Pittsburgh, Pennsylvania, USA; Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA. Electroni

Background Aims: Cancers of many different tissue origins can metastasize to the pleura, a space with a unique immune environment that predisposes to aggressive tumor behavior and the development of effusions, an exudative leakage of serous fluid accompanied by an immune infiltrate. Effusions are drained therapeutically to relieve dyspnea, often several times per week. Characteristically, they contain 50-1000 × 10 viable pleural T cells (PITs), which can be reliably activated and expanded in culture, making them an ideal source for generation of a cellular therapeutic.

View Article and Find Full Text PDF

Background: Despite effective antiretroviral (ART) use, the incidence of hepatocellular carcinoma (HCC) has not decreased in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection. Our study compared postoperative prognosis, HBV Pre-S deletion, and immune microenvironment in co-infected and HBV mono-infected individuals.

Methods: This retrospective study included 143 HBV-associated HCC patients who underwent curative resection.

View Article and Find Full Text PDF

Background: Whole-slide imaging (WSI) is increasingly becoming a standard method for diagnosing clear cell renal cell carcinoma (ccRCC). This advanced imaging technique allows for high-resolution examination of tissue sections, improving diagnosis and management of renal cancers. Immunotherapy has emerged as an effective treatment for tumors; however, the differential characteristics of the tumor microenvironment (TME) significantly influence therapeutic outcomes.

View Article and Find Full Text PDF

TGF-β and IL-12 conversely orchestrate the formation of CD103 CD8 tumor-resident memory T cells to regulate response to therapeutic cancer vaccine.

iScience

August 2025

INSERM UMR 1186, Integrative Tumor Immunology and Immunotherapy, Gustave Roussy, Fac. de Médecine-University Paris-Sud, Université Paris-Saclay, 94805 Villejuif, France.

The accumulation of CD103 CD8 tumor-resident memory T (T) cells is predictive of response to cancer immunotherapy. Here, we show that a therapeutic peptide vaccine controls tumor growth in wild-type mice, but not in CD103-knockout mice. CD8 tumor-infiltrating T lymphocytes include two major T subpopulations expressing either CD49a or CD103 integrin, with a subset co-expressing CD103 and Tcf-1.

View Article and Find Full Text PDF